BRPI0821138A2 - Aminotiazóis e seus usos - Google Patents

Aminotiazóis e seus usos

Info

Publication number: BRPI0821138A2
Authority: BR; Brazil
Prior art keywords: aminothiazoles
Prior art date: 2007-12-12

Application number

BRPI0821138-8A

Other languages

English (en)

Inventor

Simon Bushell

Matthew J Lamarche

Jennifer Leeds

Lewis Whitehead

Original Assignee

Novatis Ag

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2007-12-12

Filing date

2008-12-10

Publication date

2015-06-16

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=40377437&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BRPI0821138(A2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2008-12-10 Application filed by Novatis Ag filed Critical Novatis Ag

2015-06-16 Publication of BRPI0821138A2 publication Critical patent/BRPI0821138A2/pt

Links

RAIPHJJURHTUIC-UHFFFAOYSA-N 1,3-thiazol-2-amine Chemical class NC1=NC=CS1 RAIPHJJURHTUIC-UHFFFAOYSA-N 0.000 title 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06139—Dipeptides with the first amino acid being heterocyclic
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/427—Thiazoles not condensed and containing further heterocyclic rings
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/05—Dipeptides
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/10—Anti-acne agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Epidemiology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Immunology (AREA)
Gastroenterology & Hepatology (AREA)
Dermatology (AREA)
Oncology (AREA)
Communicable Diseases (AREA)
Genetics & Genomics (AREA)
Molecular Biology (AREA)
Biophysics (AREA)
Biochemistry (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Steroid Compounds (AREA)

BRPI0821138-8A 2007-12-12 2008-12-10 Aminotiazóis e seus usos BRPI0821138A2 (pt)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US1312207P	2007-12-12	2007-12-12
US2470908P	2008-01-30	2008-01-30
PCT/EP2008/067220 WO2009074605A1 (en)	2007-12-12	2008-12-10	Aminothiazoles and their uses

Publications (1)

Publication Number	Publication Date
BRPI0821138A2 true BRPI0821138A2 (pt)	2015-06-16

Family

ID=40377437

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
BRPI0821138-8A BRPI0821138A2 (pt)	2007-12-12	2008-12-10	Aminotiazóis e seus usos

Country Status (26)

Country	Link
US (4)	US8426356B2 (pt)
EP (1)	EP2229386B1 (pt)
JP (2)	JP5286366B2 (pt)
KR (2)	KR101187111B1 (pt)
CN (1)	CN101945866B (pt)
AR (1)	AR069628A1 (pt)
AU (1)	AU2008334659A1 (pt)
BR (1)	BRPI0821138A2 (pt)
CA (1)	CA2708793C (pt)
CL (1)	CL2008003688A1 (pt)
CO (1)	CO6290661A2 (pt)
CR (1)	CR11469A (pt)
CU (1)	CU20100119A7 (pt)
EA (2)	EA201400280A1 (pt)
EC (1)	ECSP10010244A (pt)
ES (1)	ES2542878T3 (pt)
GT (1)	GT201000166A (pt)
HN (1)	HN2010001176A (pt)
IL (1)	IL206104A (pt)
MA (1)	MA31869B1 (pt)
MY (1)	MY156466A (pt)
NZ (1)	NZ585788A (pt)
PE (1)	PE20091108A1 (pt)
TN (1)	TN2010000254A1 (pt)
TW (1)	TWI430804B (pt)
WO (1)	WO2009074605A1 (pt)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
PE20080103A1 (es) *	2006-05-31	2008-04-03	Novartis Ag	AMINOTIAZOLES COMO MODULADORES DEL FACTOR DE ELONGACION EF-Tu
CA2708793C (en) *	2007-12-12	2016-06-21	Novartis Ag	Aminothiazoles and their uses
WO2016081825A1 (en) *	2014-11-21	2016-05-26	KamTek, Inc.	Methods and compositions for treating clostridium difficile associated disease

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5202241A (en)	1988-09-09	1993-04-13	Gruppo Lepetit S.P.A.	Antibiotic GE 2270
ES2066914T3 (es)	1989-07-04	1995-03-16	Lepetit Spa	Factores a1, a2, a3 y h del antibiotico ge 2270.
DK0451486T3 (da)	1990-03-08	1995-05-08	Lepetit Spa	Antibiotikum GE 2270 faktorer B1, B2, C1, C2, D1, D2, E og T
IL100572A (en)	1991-01-03	1997-01-10	Lepetit Spa	Amides of antibiotic ge 2270 factors their preparation and pharmaceutical compositions containing them
DE69224497T2 (de)	1991-08-30	1998-07-02	Biosearch Italia Spa	Faktor C2a des Antibiotikums CE 2270
US5882900A (en)	1992-09-10	1999-03-16	Gruppo Lepetit S.P.A.	Process for the selective increase of production of antibiotic GE 2270 factor a by adding vitamin B12 to nutrient medium
DE69317058T2 (de)	1992-12-22	1998-06-10	Biosearch Italia Spa	Die antibiotika ge 37468 a, b und c
WO1996014427A1 (en)	1994-11-08	1996-05-17	Gruppo Lepetit S.P.A.	Microbial transformation process for obtaining antibiotic ge 2270 factor d¿2?
JP3518606B2 (ja)	1995-02-07	2004-04-12	バイオサーチ・イタリア・ソチエタ・ペル・アチオニ	Ｇｅ２２７０及びｇｅ２２７０−様抗生物質の塩基性オキサゾリン−アミド誘導体
ATE165101T1 (de)	1995-02-07	1998-05-15	Biosearch Italia Spa	Basische prolinamid derivate von ge2270 und ge2270-ahnlichten antibiotika
EP0880541B1 (en)	1996-02-14	2003-01-15	Biosearch Italia S.p.A.	Derivatives of antibiotic ge2270 factors
JPH1059997A (ja)	1996-08-22	1998-03-03	Microbial Chem Res Found	アミチアマイシンアミド誘導体
DK1553967T3 (da)	2002-06-17	2011-08-29	Naicons S C A R L	Anvendelse af et amidderivat af GE 2270 faktor A3 til behandling af acne
AU2005327139A1 (en)	2004-09-22	2006-08-17	Merck & Co., Inc.	Antibiotic compound
WO2007007399A1 (ja) *	2005-07-13	2007-01-18	Taisho Pharmaceutical Co., Ltd.	チアゾール系化合物
PE20080103A1 (es)	2006-05-31	2008-04-03	Novartis Ag	AMINOTIAZOLES COMO MODULADORES DEL FACTOR DE ELONGACION EF-Tu
WO2008082562A2 (en)	2006-12-20	2008-07-10	Novartis Ag	Aminothiazole macrocycles, their use as antibacterial compounds and processes for their production
AU2008258639B2 (en)	2007-06-04	2012-07-05	Novartis Ag	Macrocycles and their uses
CA2708793C (en) *	2007-12-12	2016-06-21	Novartis Ag	Aminothiazoles and their uses

2008
- 2008-12-10 CA CA2708793A patent/CA2708793C/en not_active Expired - Fee Related
- 2008-12-10 EA EA201400280A patent/EA201400280A1/ru unknown
- 2008-12-10 PE PE2008002047A patent/PE20091108A1/es not_active Application Discontinuation
- 2008-12-10 AR ARP080105359A patent/AR069628A1/es unknown
- 2008-12-10 EA EA201000890A patent/EA020205B1/ru not_active IP Right Cessation
- 2008-12-10 BR BRPI0821138-8A patent/BRPI0821138A2/pt not_active IP Right Cessation
- 2008-12-10 CN CN2008801267205A patent/CN101945866B/zh not_active Expired - Fee Related
- 2008-12-10 WO PCT/EP2008/067220 patent/WO2009074605A1/en not_active Ceased
- 2008-12-10 NZ NZ585788A patent/NZ585788A/en not_active IP Right Cessation
- 2008-12-10 ES ES08858696.1T patent/ES2542878T3/es active Active
- 2008-12-10 KR KR1020107015245A patent/KR101187111B1/ko not_active Expired - Fee Related
- 2008-12-10 JP JP2010537434A patent/JP5286366B2/ja not_active Expired - Fee Related
- 2008-12-10 EP EP08858696.1A patent/EP2229386B1/en active Active
- 2008-12-10 AU AU2008334659A patent/AU2008334659A1/en not_active Abandoned
- 2008-12-10 MY MYPI2010002527A patent/MY156466A/en unknown
- 2008-12-10 KR KR1020127006245A patent/KR20120047335A/ko not_active Withdrawn
- 2008-12-11 TW TW097148260A patent/TWI430804B/zh not_active IP Right Cessation
- 2008-12-11 CL CL2008003688A patent/CL2008003688A1/es unknown
- 2008-12-12 US US12/333,602 patent/US8426356B2/en not_active Expired - Fee Related
2010
- 2010-05-31 IL IL206104A patent/IL206104A/en active IP Right Grant
- 2010-05-31 MA MA32876A patent/MA31869B1/fr unknown
- 2010-06-01 CR CR11469A patent/CR11469A/es unknown
- 2010-06-04 TN TN2010000254A patent/TN2010000254A1/fr unknown
- 2010-06-10 GT GT201000166A patent/GT201000166A/es unknown
- 2010-06-10 CO CO10070365A patent/CO6290661A2/es active IP Right Grant
- 2010-06-11 HN HN2010001176A patent/HN2010001176A/es unknown
- 2010-06-11 EC EC2010010244A patent/ECSP10010244A/es unknown
- 2010-06-11 CU CU2010000119A patent/CU20100119A7/es not_active IP Right Cessation
2013
- 2013-04-17 US US13/864,779 patent/US20130231275A1/en not_active Abandoned
- 2013-06-06 JP JP2013120264A patent/JP2013189468A/ja active Pending
2014
- 2014-05-30 US US14/291,572 patent/US9492496B2/en not_active Expired - Fee Related
2016
- 2016-09-22 US US15/273,255 patent/US20170015704A1/en not_active Abandoned

Also Published As

Publication number	Publication date
PE20091108A1 (es)	2009-08-24
EP2229386A1 (en)	2010-09-22
US20090156628A1 (en)	2009-06-18
US8426356B2 (en)	2013-04-23
CO6290661A2 (es)	2011-06-20
IL206104A0 (en)	2010-11-30
TN2010000254A1 (en)	2011-11-11
ECSP10010244A (es)	2010-07-30
TW200932256A (en)	2009-08-01
CN101945866A (zh)	2011-01-12
AR069628A1 (es)	2010-02-03
ES2542878T3 (es)	2015-08-12
AU2008334659A1 (en)	2009-06-18
KR101187111B1 (ko)	2012-09-28
HN2010001176A (es)	2012-12-10
EP2229386B1 (en)	2015-06-03
US9492496B2 (en)	2016-11-15
US20170015704A1 (en)	2017-01-19
EA201000890A1 (ru)	2011-02-28
US20140274878A1 (en)	2014-09-18
MY156466A (en)	2016-02-26
WO2009074605A1 (en)	2009-06-18
KR20100090809A (ko)	2010-08-17
CN101945866B (zh)	2013-06-19
IL206104A (en)	2015-03-31
MA31869B1 (fr)	2010-11-01
KR20120047335A (ko)	2012-05-11
JP2013189468A (ja)	2013-09-26
EA201400280A1 (ru)	2014-08-29
NZ585788A (en)	2011-07-29
US20130231275A1 (en)	2013-09-05
GT201000166A (es)	2012-04-30
CL2008003688A1 (es)	2009-06-19
TWI430804B (zh)	2014-03-21
CU20100119A7 (es)	2011-10-14
CA2708793A1 (en)	2009-06-18
CR11469A (es)	2010-07-09
CU23908B1 (pt)	2013-06-28
EA020205B1 (ru)	2014-09-30
JP5286366B2 (ja)	2013-09-11
JP2011506394A (ja)	2011-03-03
CA2708793C (en)	2016-06-21

Legal Events

Date	Code	Title	Description
2018-03-20	B07D	Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]	Free format text: DE ACORDO COM O ARTIGO 229-C DA LEI NO 10196/2001, QUE MODIFICOU A LEI NO 9279/96, A CONCESSAO DA PATENTE ESTA CONDICIONADA A ANUENCIA PREVIA DA ANVISA. CONSIDERANDO A APROVACAO DOS TERMOS DO PARECER NO 337/PGF/EA/2010, BEM COMO A PORTARIA INTERMINISTERIAL NO 1065 DE 24/05/2012, ENCAMINHA-SE O PRESENTE PEDIDO PARA AS PROVIDENCIAS CABIVEIS.
2018-04-17	B06F	Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
2018-10-23	B08F	Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]	Free format text: REFERENTE A 10A ANUIDADE.
2019-02-12	B08K	Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]	Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2494 DE 23-10-2018 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.

Publication	Publication Date	Title
NO2025055I1 (no)	2025-12-10	Clascoterone and crystalline forms thereof
BRPI0817881A2 (pt)	2015-03-31	Compostos orgânicos e seus usos
BRPI0813244A2 (pt)	2014-12-23	Compostos e seus usos 708
BRPI0718182A2 (pt)	2014-02-25	Oligorribonucleotídeos e seus usos.
BRPI0910746A2 (pt)	2016-07-26	reticuladores e seus usos
BRPI0921862A2 (pt)	2015-12-29	inibidores de raf e seus usos
BR112012000660A2 (pt)	2016-11-16	compostos heterociclos e seus usos
BRPI1016150A2 (pt)	2016-04-19	compostos heterocíclicos e seus usos.
BRPI0913640A2 (pt)	2016-08-16	substâncias policrômicas e seus usos
BRPI0810172A2 (pt)	2014-10-14	Polipeptídeos de fator vii modificado e seus usos
BRPI0710878A2 (pt)	2015-03-31	Compostos orgânicos e seus usos
BRPI0812367A2 (pt)	2015-02-03	Dispositivos interoclusais e respectivos métodos de fabrico
BRPI0908853A2 (pt)	2017-05-30	composto oligopeptídicos e seus usos
BRPI0809103A2 (pt)	2016-08-02	composições de magnésio e seus usos
BR112012004802A2 (pt)	2015-09-08	polipeptídeos tendo atividade oxirredutase e seus usos
BRPI0817685A2 (pt)	2015-04-07	Polissacarídeos com funcionalidade azetidínio e seus usos
PT2473528E (pt)	2015-03-04	Formulações estáveis de polipéptidos e seus usos
BRPI0816165A2 (pt)	2015-02-24	Dispositivo de citaferese seletiva e seus métodos relacionados
BRPI0906387A2 (pt)	2015-07-07	Anticorpos alfa 5 - beta 1 e seus usos
BRPI0912284A2 (pt)	2015-08-18	Polímeros antimicrobianos e seus usos
BRPI0909185A2 (pt)	2015-08-25	Derivado de vitamina e e seus usos
BRPI0816372A2 (pt)	2015-02-24	Ácidos 6-fenilnicotínicos substituídos e seu uso
BRPI0814629A2 (pt)	2015-01-27	Compostos e seus efeitos sobre o comportamento alimentar
BRPI0907231A2 (pt)	2019-09-24	pirrolpirimidinas e pirrolpiridinas
BRPI0906498A2 (pt)	2015-07-14	Anticorpo ron e seus usos